2003
DOI: 10.1002/ajh.10360
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory mediators promote strong sickle cell adherence to endothelium under venular flow conditions

Abstract: Adherence of sickle erythrocytes to endothelium in venules is

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
21
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(25 citation statements)
references
References 49 publications
2
21
0
Order By: Relevance
“…RBCs express a wide range of molecules on their surface which have been implicated in mediating adhesion to endothelial cells under different conditions. These include: (i) VLA-4 (alpha4beta1) which can bind to endothelial VCAM-1 (Walmet et al, 2003); (ii) the blood group Lutheran molecule (LU) over-expressed on sRBCs can bind to laminin present on cells or in the intercellular space (Eyler and Telen, 2006); (iii) advanced glycation end products (AGEs) present on RBCs bind to their receptor (RAGE) on endothelium (Wautier and Schmidt, 2004), activating endothelial cells; and (iv) a molecule related to blood group Rhesus, ICAM-4 (Hermand et al, 2003) binds to integrins present on leukocytes (CD11–CD18) and on platelets (alpha2beta4) offering a surface which can be involved in thrombosis (reviewed by Wautier and Wautier, 2004). Thus, although PfEMP-1 does not play a role in the induction of ICAM-1 expression seen by us, it would normally be required to bring the PRBCs and ECs together in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…RBCs express a wide range of molecules on their surface which have been implicated in mediating adhesion to endothelial cells under different conditions. These include: (i) VLA-4 (alpha4beta1) which can bind to endothelial VCAM-1 (Walmet et al, 2003); (ii) the blood group Lutheran molecule (LU) over-expressed on sRBCs can bind to laminin present on cells or in the intercellular space (Eyler and Telen, 2006); (iii) advanced glycation end products (AGEs) present on RBCs bind to their receptor (RAGE) on endothelium (Wautier and Schmidt, 2004), activating endothelial cells; and (iv) a molecule related to blood group Rhesus, ICAM-4 (Hermand et al, 2003) binds to integrins present on leukocytes (CD11–CD18) and on platelets (alpha2beta4) offering a surface which can be involved in thrombosis (reviewed by Wautier and Wautier, 2004). Thus, although PfEMP-1 does not play a role in the induction of ICAM-1 expression seen by us, it would normally be required to bring the PRBCs and ECs together in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…21, 22 The binding of sickle erythrocytes to endothelial cell-immobilized VWF could also increase hemolysis by slowing erythrocyte transit enough to induce hemoglobin deoxygenation and polymerization, consistent with the finding that sickle erythrocyte adhesion to ULVWF was highest at a fluid shear stress of 0.5 dyne/cm 2 , approximately that of postcapillary venules. 23 Hyperreactive VWF probably accumulates in SCD by a combination of increased secretion, defective clearance, and impaired processing by ADAMTS13. Impaired processing is not the result of ADAMTS13 deficiency but could reflect resistance of VWF to proteolysis, possibly because of oxidation of Met1606 at the ADAMTS13 cleavage site.…”
Section: Adamts13 Antigen and Activitymentioning
confidence: 99%
“…During acute infections, these proteins facilitate the attachment of leukocytes to the vessel wall, ultimately resulting in transmigration into infected tissue 6. In SCA, variable TNF-α signaling might alter disease severity by activating systemic and pulmonary endothelium and by modulating rates of sickle vasoocclusion secondary to altered leukocyte-endothelial cell adhesion 7, 8. Associations between some individual clinical complications of SCA and plasma levels of VCAM-1 and ICAM-1, but not TNF-R1, have been described previously.…”
mentioning
confidence: 99%